Back

The Drug-Induced Respiratory Disease Website and App

XV.h

XV - Pathology

Path: NSIP-fibrotic pattern

Last update 12/01/2020

Including fibrotic NSIP and fibrosis not otherwise specified, as found in older literature. See also under Ig and XV. PMID 27628326

Causative drugs

32

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

Amiodarone
I.a
I.b
I.c
I.d
I.e
I.f
I.g
I.h
I.k
I.l
I.s
I.u
I.w
I.z
I.aa
I.ao
I.at
I.ax
I.ay
II.b
II.l
III.a
III.c
IV.a
IV.d
IV.r
V.a
V.c
V.d
V.t
VI.a
VI.i
VIII.a
IX.a
IX.d
IX.ai
X.d
X.f
X.q
XI.c
XI.f
XII.a
XII.c
XII.e
XII.l
XII.n
XII.p
XII.t
XII.af
XII.au
XV.a
XV.b
XV.c
XV.d
XV.f
XV.g
XV.h
XV.i
XV.j
XV.k
XV.m
XV.o
XV.r
XV.ao
XV.bt
XV.co
XV.dc
XVI.b
XVI.i
XVI.j
XVI.n
XVI.s
XVI.w
XVI.aa
XVI.ab
XVI.ay
XVI.az
XVI.bj
XVI.bq
XVI.bt
XVI.bx
XVI.ca
XVII.e
XVIII.b
XVIII.j
XVIII.k
XVIII.p
XIX.a
XIX.b
XIX.c
XIX.e
XIX.f
XIX.m
XIX.p
XXVIII.c
Bleomycin
I.a
I.b
I.c
I.d
I.f
I.g
I.k
I.l
I.p
I.v
I.w
II.b
II.t
V.f
V.p
V.z
VI.c
VI.f
VII.e
VII.h
XI.b
XI.c
XV.a
XV.b
XV.c
XV.d
XV.f
XV.h
XV.i
XV.j
XV.l
XV.ax
XV.be
XV.bf
XVI.a
XVI.b
XVI.e
XVI.k
XVI.w
XVI.ab
XVI.af
XVI.bl
XVIII.j
XIX.b
XXIV.a
XXIV.b
Busulfan
I.a
I.b
I.d
I.g
I.l
I.n
I.v
II.b
VI.b
XV.a
XV.c
XV.d
XV.f
XV.h
XV.i
XV.n
XV.bc
XVI.d
XVII.f
XIX.g
Carmustine (BCNU)
I.a
I.b
I.g
I.l
I.x
I.ad
II.a
II.b
V.a
V.f
V.m
V.ab
XII.c
XV.a
XV.f
XV.h
XV.i
XV.ap
XVI.a
XVI.b
XVI.m
Chlorozotocin (DCNU)
I.b
I.g
XV.h
Cocaine
I.c
I.d
I.e
I.t
I.z
II.a
II.d
III.a
III.b
III.c
III.n
IV.a
IV.f
IV.o
V.f
V.ab
VI.a
VI.b
VI.l
VII.h
VIII.a
VIII.c
VIII.i
VIII.m
VIII.w
VIII.ah
VIII.ai
VIII.ak
VIII.ap
VIII.aw
IX.k
IX.o
X.f
X.h
X.j
X.m
X.o
X.s
X.u
X.x
X.ac
X.ad
X.as
XI.b
XI.j
XI.k
XI.n
XI.aa
XI.at
XII.a
XII.e
XII.f
XII.g
XII.l
XII.y
XII.ae
XII.af
XII.aj
XII.ap
XIV.c
XV.b
XV.g
XV.h
XV.s
XV.w
XV.aw
XVI.k
XVII.b
Cyclophosphamide
I.a
I.b
I.d
I.g
I.l
I.x
I.aa
II.a
II.b
III.a
IV.a
V.a
V.b
V.c
V.f
VI.c
IX.f
X.f
XI.b
XI.c
XI.l
XII.a
XII.c
XII.f
XII.g
XII.s
XV.a
XV.c
XV.f
XV.h
XV.i
XV.ak
XV.ap
XVI.ap
XVI.bl
XVII.b
XVII.e
XVII.q
XIX.a
Docetaxel
I.a
I.b
I.g
II.a
II.b
II.j
III.a
V.a
X.c
X.g
X.n
X.r
XII.c
XII.m
XV.a
XV.f
XV.h
Hair spray
I.b
XV.h
Hairspray
I.b
XV.h
XVI.u
Ifosfamide
I.b
I.g
I.ad
II.a
II.d
XI.a
XII.f
XII.l
XII.n
XIV.a
XV.h
XV.j
Imatinib
I.a
I.b
I.c
I.d
I.m
I.n
I.y
II.b
II.d
III.a
V.a
V.c
V.i
V.m
V.ah
X.a
X.n
X.r
XII.a
XII.c
XII.f
XIII.g
XV.a
XV.c
XV.h
XV.n
XV.ch
XVI.ca
XVII.g
XVII.h
XVII.o
XVII.w
Irinotecan
I.b
II.b
III.a
XV.a
XV.f
XV.h
XV.i
Melphalan
I.a
I.g
I.v
II.b
IV.a
X.f
XV.c
XV.h
XV.i
XV.j
Mercury fumes/vapor
I.a
I.b
I.g
I.w
I.af
II.a
II.b
II.t
IV.t
IV.al
XII.l
XII.ah
XV.a
XV.f
XV.h
Loading more…